Volume 15, Number 2—February 2009
Dispatch
Mycobacterium bolletii Respiratory Infections
Toïdi Adékambi1 and Michel Drancourt
Table
Antimicrobial drug susceptibility test results (MICs) for Mycobacterium bolletii isolates*
| Antimicrobial agent | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
|---|---|---|---|---|
| Penicillin | >32 | >32 | >32 | >32 |
| Amoxicillin | >256 | >256 | >256 | >256 |
| Amoxicillin clavulanate (disc 20 µg + 10 µg) | >4 | >4 | >4 | >4 |
| Cefoxitin | >256 | >256 | >256 | >256 |
| Ceftriaxone | >256 | >256 | >256 | >256 |
| Cefotaxime | >256 | >256 | >256 | >256 |
| Imipenen | >32 | >32 | >32 | >32 |
| Doxycycline | >32 | >32 | >32 | >32 |
| Minocycline | >256 | >256 | >256 | >256 |
| Clarithromycin | >256 | >256 | >256 | >256 |
| Erythromycin | >256 | >256 | >256 | >256 |
| Azithromycin | >256 | >256 | >256 | >256 |
| Amikacin | 32 | 48 | 32 | 48 |
| Tobramycin | >32 | >32 | >32 | >32 |
| Ciprofloxacin | >32 | >32 | >32 | >32 |
| Ofloxacin | >32 | >32 | >32 | >32 |
| Sparfloxacin | >32 | >32 | >32 | >32 |
| Rifampicin | >32 | >32 | >32 | >32 |
| Metronidazole | >256 | >256 | >256 | >256 |
| Teicoplanine | >256 | >256 | >256 | >256 |
| Vancomycin | >256 | >256 | >256 | >256 |
| Trimethoprim-sulfamethoxazole | >32 | >32 | >32 | >32 |
*Values given in μg/mL.
Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.